New Regulatory Changes: Waiving Local Clinical Trials for Foreign-Approved Drugs in India
The recent regulatory changes introduced by the Drug Controller General of India (DGCI) signify a pivotal shift in India’s pharmaceutical landscape. Under the new guidelines, drugs that have already received…